IBDEI0L2 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=INTERVENTION^2^20
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=CCHT VIDEO^4^20
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=OTHER^4^21
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=CARDIOLOGY/EKG^1^21
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=TELEBUDDY EDUCATION^5^21
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=CCHT MONTHLY MONITOR^3^21
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=CCHT HOME VISIT^2^21
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=PRIMARY DIAGNOSIS^1^22
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;="A" MISC DIAGNOSIS^1^23
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;="B" MISC DIAGNOSIS^4^23
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;="C" MISC DIAGNOSIS^7^23
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;="D" MISC DIAGNOSIS^8^23
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;="E/F" MISC DIAGNOSIS^11^23
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;="H" MISC DIAGNOSIS^13^23
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;="I" MISC DIAGNOSIS^14^23
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;="J/K/L" MISC DIAGNOSIS^15^23
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;="M" MISC DIAGNOSIS^16^23
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;="N/O" MISC DISGNOSIS^17^23
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;="P" MISC DIAGNOSIS^18^23
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;="V/W/X/Y/Z" MISC DIAGNOSIS^28^23
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;="S" MISC DIAGNOSIS^22^23
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=CANCER (NOT MELANOMA)^6^23
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;="G" MISC DIAGNOSIS^12^23
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;="R" DIAGNOSES^21^23
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;="T/U" MISC DIAGNOSIS^27^23
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=  ADJUSTMENT REACTION^2^23
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=  ANXIETY DISORDER^3^23
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=  BIPOLAR DISORDERS^5^23
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=  DEMENTIA^9^23
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=  DEPRESSION^10^23
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=  PAIN^19^23
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=  PERSONALITY DISORDERS^20^23
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=  SCHIZOPHRENIC DISORDERS^23^23
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=  SUBSTANCE ABUSE^24^23
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=SCREENING^25^23
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=SYMPTOMS^26^23
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=OTHER DIAGNOSES^29^23
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=V-CODES^30^23
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=  TELEHEALTH-SECONDARY ONLY^31^23
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=OTHER^4^24
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=TELEBUDDY EDUCATION^4^24
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=CCHT MONTHLY MONITOR^3^24
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=CCHT HOME VISIT^2^24
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=TELEPSYCH^5^24
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=CASE MANAGEMENT^1^24
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=PRIMARY DIAGNOSIS^1^25
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;="A" MISC DIAGNOSIS^1^26
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;="B" MISC DIAGNOSIS^4^26
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;="C" MISC DIAGNOSIS^7^26
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;="D" MISC DIAGNOSIS^8^26
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;="E/F" MISC DIAGNOSIS^11^26
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;="H" MISC DIAGNOSIS^13^26
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;="I" MISC DIAGNOSIS^14^26
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;="J/K/L" MISC DIAGNOSIS^15^26
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;="M" MISC DIAGNOSIS^16^26
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;="N/O" MISC DISGNOSIS^17^26
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;="P" MISC DIAGNOSIS^18^26
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;="V/W/X/Y/Z" MISC DIAGNOSIS^28^26
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;="S" MISC DIAGNOSIS^22^26
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=CANCER (NOT MELANOMA)^6^26
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;="G" MISC DIAGNOSIS^12^26
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;="R" DIAGNOSES^21^26
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;="T/U" MISC DIAGNOSIS^27^26
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=  ADJUSTMENT REACTION^2^26
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=  ANXIETY DISORDER^3^26
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=  BIPOLAR DISORDERS^5^26
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=  DEMENTIA^9^26
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=  DEPRESSION^10^26
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=  PAIN^19^26
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=  PERSONALITY DISORDERS^20^26
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=  SCHIZOPHRENIC DISORDERS^23^26
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=  SUBSTANCE ABUSE^24^26
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=SCREENING^25^26
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=SYMPTOMS^26^26
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=OTHER DIAGNOSES^29^26
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=V-CODES^30^26
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=  TELEHEALTH-SECONDARY ONLY^31^26
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=SPECIAL SERVICES^6^27
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=CHEMO NURSE PROCEDURES^2^27
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=INFUSION DRUGS^4^27
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=BLOOD PRODUCTS^1^27
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=DIAGNOSTIC PROCEDURES^3^27
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=OTHER DRUGS^5^27
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=NEW PATIENT^2^28
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=ESTABLISHED PATIENT^1^28
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=CONSULTATIONS^3^28
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=ANEMIA^1^29
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=COAGULATION DISORDERS^4^29
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^12^29
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=LYMPHOID NEOPLASMS^9^29
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=GI NEOPLASMS^7^29
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^29
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=MISC. NEOPLASMS^11^29
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=METASTATIC SITES^10^29
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=COUNSELING & SCREENING^5^29
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=GENITOURINARY NEOPLASMS^6^29
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=BREAST & GYN NEOPLASMS^3^29
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=ARTIFICIAL OPENING STATUS^2^29
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=PERSONAL HX OF CANCER^15^29
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=NEOPLASMS OF UNCERTAIN BEHAVIOR^13^29
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=NEOPLASMS OF UNSPECIFIED NATURE^14^29
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=NEW PATIENT^2^30
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=ESTABLISHED PATIENT^1^30
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=CONSULTATIONS^3^30
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^1^31
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=MISCELLANEOUS TREATMENT^4^32
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^32
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^3^32
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=ACUPUNCTURE^1^32
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=SECONDARY V CODES AS APPROPRIATE^1^33
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=C&P EXAM^1^34
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=IDES C&P EXAM^3^34
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=ACE C&P EXAM^2^34
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=LENGTHY/COMPLEX C-FILE REVIEW^1^35
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=PRIMARY DIAGNOSIS^1^36
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=INPATIENT ADMISSION VISIT^2^37
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=INPATIENT CONSULTS^1^37
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=INPATIENT SUBSEQUENT VISIT^3^37
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=DISCHARGE VISIT^4^37
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=OBSERVATION ADMISSION^5^37
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=OBSERVATION DISCHARGE^6^37
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=INTENSIVE CARE^8^37
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^7^37
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=CARDIAC^2^38
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=ENDOCRINE/METABOLIC^5^38
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=PULMONARY^20^38
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=EENT^4^38
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=MUSCULOSKELETAL^13^38
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=NEUROLOGIC^14^38
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=MENTAL HEALTH^12^38
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=GASTROENTEROLOGY^6^38
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=GU / RENAL^7^38
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=CANCER^3^38
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=HEMATOLOGIC & LYMPHATIC^8^38
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=INFECTIOUS DISEASE^10^38
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=SKIN^24^38
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^22^38
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=INTERSTITIAL LUNG DISEASE^11^38
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=PAIN^18^38
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=OTHER^17^38
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=COMMON PULMONARY DIAGNOSES^1^38
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^38
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=OCCUPATIONAL^16^38
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=PLEURAL DISEASE^19^38
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=RADIATION^21^38
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=SKELETAL^23^38
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=HEPATIC & BILIARY^9^38
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=SUTURES/DRESSINGS^25^38
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=VASCULAR^26^38
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=BEDSIDE PROCEDURES^1^39
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=BLOODS,ARTERIAL & VENOUS^2^39
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=BRONCHOSCOPY^3^39
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=EXERCISE TESTING^4^39
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=OXIMETRY^5^39
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=PULMONARY FUCTION TESTING^6^39
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=RESPIRATORY THERAPY^7^39
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=THORACENTESIS^8^39
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=NEW PATIENT^2^40
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=ESTABLISHED PATIENT^1^40
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=CONSULTATIONS^3^40
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=POST-OP COMPLICATIONS^16^41
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^41
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=GYN/BREAST^8^41
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=MALE BREAST^10^41
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=BENIGN LESIONS OF SKIN^3^41
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^41
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=MELANOMA^12^41
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=LACERATIONS^9^41
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=MERKEL CELL CANCER^13^41
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=AFTERCARE POST SURGERY^2^41
